Constantin N. Baxevanis

The traditional and a new version of the mouse H–2 complex

J. Klein, Z. Nagy, C. Baxevanis, 1981, Nature.

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RI

A. Kretsovali, J. Papamatheakis, A. Mamalaki, 2003, Cancer Immunology, Immunotherapy.

Prostate cancer vaccines: the long road to clinical application

S. Perez, M. Papamichail, C. Baxevanis, 2015, Cancer Immunology, Immunotherapy.

AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction

S. Perez, M. Papamichail, C. Baxevanis, 2014, Cancer Immunology, Immunotherapy.

A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

M. Karamouzis, P. Kountourakis, S. Perez, 2010, Cancer Immunology, Immunotherapy.